【Description】
An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Active Pharmaceutical Ingredients (API) was estimated at US$ 77250 million in the year 2022, is projected to reach a revised size of US$ 113360 million by 2029, growing at a CAGR of 6.6% during the forecast period 2023-2029.
India is the largest region of Active Pharmaceutical Ingredients (API), with a market share about 30%. Teva Active Pharmaceutical Industries Limited, DSM, Novartis, Roche and Johnson & Johnson are the top 5 manufacturers of industry.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Active Pharmaceutical Ingredients (API), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Active Pharmaceutical Ingredients (API).
The Active Pharmaceutical Ingredients (API) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Active Pharmaceutical Ingredients (API) market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Active Pharmaceutical Ingredients (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
Market Segmentation
This report covers the Active Pharmaceutical Ingredients (API) segments by manufacturers, by type, by application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2018-2023, 2024-2029), considering 2022 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
By Company
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
Segment by Type
Synthetic APIs
Biotech APIs
Segment by Application
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter Two: Detailed analysis of Active Pharmaceutical Ingredients (API) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger and acquisition information, etc.
Chapter Three: Sales, revenue of Active Pharmaceutical Ingredients (API) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
【Table of Contents】
1 Active Pharmaceutical Ingredients (API) Market Overview
1.1 Active Pharmaceutical Ingredients (API) Product Overview
1.2 Active Pharmaceutical Ingredients (API) Market Segment by Type
1.2.1 Synthetic APIs
1.2.2 Biotech APIs
1.3 Global Active Pharmaceutical Ingredients (API) Market Size by Type
1.3.1 Global Active Pharmaceutical Ingredients (API) Market Size Overview by Type (2018-2029)
1.3.2 Global Active Pharmaceutical Ingredients (API) Historic Market Size Review by Type (2018-2023)
1.3.3 Global Active Pharmaceutical Ingredients (API) Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Active Pharmaceutical Ingredients (API) Sales Breakdown by Type (2018-2023)
1.4.2 Europe Active Pharmaceutical Ingredients (API) Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Active Pharmaceutical Ingredients (API) Sales Breakdown by Type (2018-2023)
1.4.4 I194 Active Pharmaceutical Ingredients (API) Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Breakdown by Type (2018-2023)
2 Global Active Pharmaceutical Ingredients (API) Market Competition by Company
2.1 Global Top Players by Active Pharmaceutical Ingredients (API) Sales (2018-2023)
2.2 Global Top Players by Active Pharmaceutical Ingredients (API) Revenue (2018-2023)
2.3 Global Top Players by Active Pharmaceutical Ingredients (API) Price (2018-2023)
2.4 Global Top Manufacturers Active Pharmaceutical Ingredients (API) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Active Pharmaceutical Ingredients (API) Market Competitive Situation and Trends
2.5.1 Active Pharmaceutical Ingredients (API) Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Active Pharmaceutical Ingredients (API) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredients (API) as of 2022)
2.7 Date of Key Manufacturers Enter into Active Pharmaceutical Ingredients (API) Market
2.8 Key Manufacturers Active Pharmaceutical Ingredients (API) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Active Pharmaceutical Ingredients (API) Status and Outlook by Region
3.1 Global Active Pharmaceutical Ingredients (API) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Active Pharmaceutical Ingredients (API) Historic Market Size by Region
3.2.1 Global Active Pharmaceutical Ingredients (API) Sales in Volume by Region (2018-2023)
3.2.2 Global Active Pharmaceutical Ingredients (API) Sales in Value by Region (2018-2023)
3.2.3 Global Active Pharmaceutical Ingredients (API) Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Active Pharmaceutical Ingredients (API) Forecasted Market Size by Region
3.3.1 Global Active Pharmaceutical Ingredients (API) Sales in Volume by Region (2024-2029)
3.3.2 Global Active Pharmaceutical Ingredients (API) Sales in Value by Region (2024-2029)
3.3.3 Global Active Pharmaceutical Ingredients (API) Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Active Pharmaceutical Ingredients (API) by Application
4.1 Active Pharmaceutical Ingredients (API) Market Segment by Application
4.1.1 CNS
4.1.2 Cardiovascular
4.1.3 Genitourinary/Hormonal Drugs
4.1.4 Respiratory
4.1.5 Rheumatology
4.1.6 Diabetes
4.1.7 Oncology
4.1.8 Others
4.2 Global Active Pharmaceutical Ingredients (API) Market Size by Application
4.2.1 Global Active Pharmaceutical Ingredients (API) Market Size Overview by Application (2018-2029)
4.2.2 Global Active Pharmaceutical Ingredients (API) Historic Market Size Review by Application (2018-2023)
4.2.3 Global Active Pharmaceutical Ingredients (API) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Active Pharmaceutical Ingredients (API) Sales Breakdown by Application (2018-2023)
4.3.2 Europe Active Pharmaceutical Ingredients (API) Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Active Pharmaceutical Ingredients (API) Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Active Pharmaceutical Ingredients (API) Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Breakdown by Application (2018-2023)
5 North America Active Pharmaceutical Ingredients (API) by Country
5.1 North America Active Pharmaceutical Ingredients (API) Historic Market Size by Country
5.1.1 North America Active Pharmaceutical Ingredients (API) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2018-2023)
5.1.3 North America Active Pharmaceutical Ingredients (API) Sales in Value by Country (2018-2023)
5.2 North America Active Pharmaceutical Ingredients (API) Forecasted Market Size by Country
5.2.1 North America Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2024-2029)
5.2.2 North America Active Pharmaceutical Ingredients (API) Sales in Value by Country (2024-2029)
6 Europe Active Pharmaceutical Ingredients (API) by Country
6.1 Europe Active Pharmaceutical Ingredients (API) Historic Market Size by Country
6.1.1 Europe Active Pharmaceutical Ingredients (API) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2018-2023)
6.1.3 Europe Active Pharmaceutical Ingredients (API) Sales in Value by Country (2018-2023)
6.2 Europe Active Pharmaceutical Ingredients (API) Forecasted Market Size by Country
6.2.1 Europe Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2024-2029)
6.2.2 Europe Active Pharmaceutical Ingredients (API) Sales in Value by Country (2024-2029)
7 Asia-Pacific Active Pharmaceutical Ingredients (API) by Region
7.1 Asia-Pacific Active Pharmaceutical Ingredients (API) Historic Market Size by Region
7.1.1 Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Active Pharmaceutical Ingredients (API) Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Active Pharmaceutical Ingredients (API) Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Active Pharmaceutical Ingredients (API) Forecasted Market Size by Region
7.2.1 Asia-Pacific Active Pharmaceutical Ingredients (API) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Active Pharmaceutical Ingredients (API) Sales in Value by Region (2024-2029)
8 Latin America Active Pharmaceutical Ingredients (API) by Country
8.1 Latin America Active Pharmaceutical Ingredients (API) Historic Market Size by Country
8.1.1 Latin America Active Pharmaceutical Ingredients (API) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2018-2023)
8.1.3 Latin America Active Pharmaceutical Ingredients (API) Sales in Value by Country (2018-2023)
8.2 Latin America Active Pharmaceutical Ingredients (API) Forecasted Market Size by Country
8.2.1 Latin America Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2024-2029)
8.2.2 Latin America Active Pharmaceutical Ingredients (API) Sales in Value by Country (2024-2029)
9 Middle East and Africa Active Pharmaceutical Ingredients (API) by Country
9.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Historic Market Size by Country
9.1.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Forecasted Market Size by Country
9.2.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Teva
10.1.1 Teva Company Information
10.1.2 Teva Introduction and Business Overview
10.1.3 Teva Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Teva Active Pharmaceutical Ingredients (API) Products Offered
10.1.5 Teva Recent Development
10.2 Mylan
10.2.1 Mylan Company Information
10.2.2 Mylan Introduction and Business Overview
10.2.3 Mylan Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Mylan Active Pharmaceutical Ingredients (API) Products Offered
10.2.5 Mylan Recent Development
10.3 DSM
10.3.1 DSM Company Information
10.3.2 DSM Introduction and Business Overview
10.3.3 DSM Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.3.4 DSM Active Pharmaceutical Ingredients (API) Products Offered
10.3.5 DSM Recent Development
10.4 Aurobindo Pharma
10.4.1 Aurobindo Pharma Company Information
10.4.2 Aurobindo Pharma Introduction and Business Overview
10.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Products Offered
10.4.5 Aurobindo Pharma Recent Development
10.5 Aspen
10.5.1 Aspen Company Information
10.5.2 Aspen Introduction and Business Overview
10.5.3 Aspen Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Aspen Active Pharmaceutical Ingredients (API) Products Offered
10.5.5 Aspen Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Novartis Active Pharmaceutical Ingredients (API) Products Offered
10.6.5 Novartis Recent Development
10.7 BASF
10.7.1 BASF Company Information
10.7.2 BASF Introduction and Business Overview
10.7.3 BASF Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.7.4 BASF Active Pharmaceutical Ingredients (API) Products Offered
10.7.5 BASF Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Information
10.8.2 Pfizer Introduction and Business Overview
10.8.3 Pfizer Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Pfizer Active Pharmaceutical Ingredients (API) Products Offered
10.8.5 Pfizer Recent Development
10.9 Huahai Pharmaceutical
10.9.1 Huahai Pharmaceutical Company Information
10.9.2 Huahai Pharmaceutical Introduction and Business Overview
10.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Products Offered
10.9.5 Huahai Pharmaceutical Recent Development
10.10 Hisun Pharmaceutical
10.10.1 Hisun Pharmaceutical Company Information
10.10.2 Hisun Pharmaceutical Introduction and Business Overview
10.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Products Offered
10.10.5 Hisun Pharmaceutical Recent Development
10.11 Sun Pharmaceutical Industries
10.11.1 Sun Pharmaceutical Industries Company Information
10.11.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Products Offered
10.11.5 Sun Pharmaceutical Industries Recent Development
10.12 Zhejiang Medicine
10.12.1 Zhejiang Medicine Company Information
10.12.2 Zhejiang Medicine Introduction and Business Overview
10.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Products Offered
10.12.5 Zhejiang Medicine Recent Development
10.13 Dr. Reddy’s Laboratories
10.13.1 Dr. Reddy’s Laboratories Company Information
10.13.2 Dr. Reddy’s Laboratories Introduction and Business Overview
10.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Products Offered
10.13.5 Dr. Reddy’s Laboratories Recent Development
10.14 Zhejiang NHU
10.14.1 Zhejiang NHU Company Information
10.14.2 Zhejiang NHU Introduction and Business Overview
10.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Zhejiang NHU Active Pharmaceutical Ingredients (API) Products Offered
10.14.5 Zhejiang NHU Recent Development
10.15 Bayer
10.15.1 Bayer Company Information
10.15.2 Bayer Introduction and Business Overview
10.15.3 Bayer Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Bayer Active Pharmaceutical Ingredients (API) Products Offered
10.15.5 Bayer Recent Development
10.16 NCPC
10.16.1 NCPC Company Information
10.16.2 NCPC Introduction and Business Overview
10.16.3 NCPC Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.16.4 NCPC Active Pharmaceutical Ingredients (API) Products Offered
10.16.5 NCPC Recent Development
10.17 AbbVie
10.17.1 AbbVie Company Information
10.17.2 AbbVie Introduction and Business Overview
10.17.3 AbbVie Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.17.4 AbbVie Active Pharmaceutical Ingredients (API) Products Offered
10.17.5 AbbVie Recent Development
10.18 Shandong Xinhua Pharmaceutical
10.18.1 Shandong Xinhua Pharmaceutical Company Information
10.18.2 Shandong Xinhua Pharmaceutical Introduction and Business Overview
10.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Products Offered
10.18.5 Shandong Xinhua Pharmaceutical Recent Development
10.19 Northeast Pharm
10.19.1 Northeast Pharm Company Information
10.19.2 Northeast Pharm Introduction and Business Overview
10.19.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Northeast Pharm Active Pharmaceutical Ingredients (API) Products Offered
10.19.5 Northeast Pharm Recent Development
10.20 Harbin Pharmaceutical
10.20.1 Harbin Pharmaceutical Company Information
10.20.2 Harbin Pharmaceutical Introduction and Business Overview
10.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Products Offered
10.20.5 Harbin Pharmaceutical Recent Development
10.21 LKPC
10.21.1 LKPC Company Information
10.21.2 LKPC Introduction and Business Overview
10.21.3 LKPC Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2018-2023)
10.21.4 LKPC Active Pharmaceutical Ingredients (API) Products Offered
10.21.5 LKPC Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Active Pharmaceutical Ingredients (API) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Active Pharmaceutical Ingredients (API) Industrial Chain Analysis
11.4 Active Pharmaceutical Ingredients (API) Market Dynamics
11.4.1 Active Pharmaceutical Ingredients (API) Industry Trends
11.4.2 Active Pharmaceutical Ingredients (API) Market Drivers
11.4.3 Active Pharmaceutical Ingredients (API) Market Challenges
11.4.4 Active Pharmaceutical Ingredients (API) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Active Pharmaceutical Ingredients (API) Distributors
12.3 Active Pharmaceutical Ingredients (API) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
【Table of Figures】
List of Tables
Table 1. Major Company of Synthetic APIs
Table 2. Major Company of Biotech APIs
Table 3. Global Active Pharmaceutical Ingredients (API) Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Active Pharmaceutical Ingredients (API) Sales by Type (2018-2023) & (Tons)
Table 5. Global Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Type (2018-2023)
Table 6. Global Active Pharmaceutical Ingredients (API) Sales by Type (2018-2023) & (US& Million)
Table 7. Global Active Pharmaceutical Ingredients (API) Market Share in Value by Type (2018-2023)
Table 8. Global Active Pharmaceutical Ingredients (API) Price by Type (2018-2023) & (USD/Ton)
Table 9. Global Active Pharmaceutical Ingredients (API) Sales by Type (2024-2029) & (Tons)
Table 10. Global Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Active Pharmaceutical Ingredients (API) Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Type (2024-2029)
Table 13. Global Active Pharmaceutical Ingredients (API) Price by Type (2024-2029) & (USD/Ton)
Table 14. North America Active Pharmaceutical Ingredients (API) Sales by Type (2018-2023) & (Tons)
Table 15. North America Active Pharmaceutical Ingredients (API) Sales by Type (2018-2023) & (US$ Million)
Table 16. Europe Active Pharmaceutical Ingredients (API) Sales (Tons) by Type (2018-2023)
Table 17. Europe Active Pharmaceutical Ingredients (API) Sales by Type (2018-2023) & (US$ Million)
Table 18. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales (Tons) by Type (2018-2023)
Table 19. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Type (2018-2023) & (US$ Million)
Table 20. Latin America Active Pharmaceutical Ingredients (API) Sales (Tons) by Type (2018-2023)
Table 21. Latin America Active Pharmaceutical Ingredients (API) Sales by Type (2018-2023) & (US$ Million)
Table 22. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales (Tons) by Type (2018-2023)
Table 23. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Type (2018-2023) & (US$ Million)
Table 24. Global Active Pharmaceutical Ingredients (API) Sales by Company (2018-2023) & (Tons)
Table 25. Global Active Pharmaceutical Ingredients (API) Sales Share by Company (2018-2023)
Table 26. Global Active Pharmaceutical Ingredients (API) Revenue by Company (2018-2023) & (US$ Million)
Table 27. Global Active Pharmaceutical Ingredients (API) Revenue Share by Company (2018-2023)
Table 28. Global Market Active Pharmaceutical Ingredients (API) Price by Company (2018-2023) & (USD/Ton)
Table 29. Global Active Pharmaceutical Ingredients (API) Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Active Pharmaceutical Ingredients (API) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredients (API) as of 2022)
Table 32. Date of Key Manufacturers Enter into Active Pharmaceutical Ingredients (API) Market
Table 33. Key Manufacturers Active Pharmaceutical Ingredients (API) Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Active Pharmaceutical Ingredients (API) Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Active Pharmaceutical Ingredients (API) Sales by Region (2018-2023) & (Tons)
Table 37. Global Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Region (2018-2023)
Table 38. Global Active Pharmaceutical Ingredients (API) Sales by Region (2018-2023) & (US$ Million)
Table 39. Global Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Region (2018-2023)
Table 40. Global Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 41. Global Active Pharmaceutical Ingredients (API) Sales by Region (2024-2029) & (Tons)
Table 42. Global Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Active Pharmaceutical Ingredients (API) Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Region (2024-2029)
Table 45. Global Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2024-2029)
Table 46. Global Active Pharmaceutical Ingredients (API) Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Active Pharmaceutical Ingredients (API) Sales by Application (2018-2023) & (Tons)
Table 48. Global Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Application (2018-2023)
Table 49. Global Active Pharmaceutical Ingredients (API) Sales by Application (2018-2023) & (US$ Million)
Table 50. Global Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Application (2018-2023)
Table 51. Global Active Pharmaceutical Ingredients (API) Price by Application (2018-2023) & (USD/Ton)
Table 52. Global Active Pharmaceutical Ingredients (API) Sales by Application (2024-2029) & (Tons)
Table 53. Global Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Active Pharmaceutical Ingredients (API) Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Application (2024-2029)
Table 56. Global Active Pharmaceutical Ingredients (API) Price by Application (2024-2029) & (USD/Ton)
Table 57. North America Active Pharmaceutical Ingredients (API) Sales by Application (2018-2023) (Tons)
Table 58. North America Active Pharmaceutical Ingredients (API) Sales by Application (2018-2023) & (US$ Million)
Table 59. Europe Active Pharmaceutical Ingredients (API) Sales by Application (2018-2023) (Tons)
Table 60. Europe Active Pharmaceutical Ingredients (API) Sales by Application (2018-2023) & (US$ Million)
Table 61. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Application (2018-2023) (Tons)
Table 62. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Application (2018-2023) & (US$ Million)
Table 63. Latin America Active Pharmaceutical Ingredients (API) Sales by Application (2018-2023) (Tons)
Table 64. Latin America Active Pharmaceutical Ingredients (API) Sales by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Application (2018-2023) (Tons)
Table 66. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Application (2018-2023) & (US$ Million)
Table 67. North America Active Pharmaceutical Ingredients (API) Sales by Country (2018-2023) & (Tons)
Table 68. North America Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Country (2018-2023)
Table 69. North America Active Pharmaceutical Ingredients (API) Sales by Country (2018-2023) & (US$ Million)
Table 70. North America Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Country (2018-2023)
Table 71. North America Active Pharmaceutical Ingredients (API) Sales by Country (2024-2029) & (Tons)
Table 72. North America Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Active Pharmaceutical Ingredients (API) Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2018-2023) & (Tons)
Table 76. Europe Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Country (2018-2023)
Table 77. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2018-2023) & (US$ Million)
Table 78. Europe Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Country (2018-2023)
Table 79. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2024-2029) & (Tons)
Table 80. Europe Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Region (2018-2023) & (Tons)
Table 84. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Region (2018-2023)
Table 85. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Region (2018-2023) & (US$ Million)
Table 86. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Region (2018-2023)
Table 87. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Region (2024-2029) & (Tons)
Table 88. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Active Pharmaceutical Ingredients (API) Sales by Country (2018-2023) & (Tons)
Table 92. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Country (2018-2023)
Table 93. Latin America Active Pharmaceutical Ingredients (API) Sales by Country (2018-2023) & (US$ Million)
Table 94. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Country (2018-2023)
Table 95. Latin America Active Pharmaceutical Ingredients (API) Sales by Country (2024-2029) & (Tons)
Table 96. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Active Pharmaceutical Ingredients (API) Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Country (2018-2023) & (Tons)
Table 100. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Country (2018-2023)
Table 101. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Country (2018-2023) & (US$ Million)
Table 102. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Country (2018-2023)
Table 103. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Country (2024-2029) & (Tons)
Table 104. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Country (2024-2029)
Table 107. Teva Company Information
Table 108. Teva Introduction and Business Overview
Table 109. Teva Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 110. Teva Active Pharmaceutical Ingredients (API) Product
Table 111. Teva Recent Development
Table 112. Mylan Company Information
Table 113. Mylan Introduction and Business Overview
Table 114. Mylan Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 115. Mylan Active Pharmaceutical Ingredients (API) Product
Table 116. Mylan Recent Development
Table 117. DSM Company Information
Table 118. DSM Introduction and Business Overview
Table 119. DSM Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 120. DSM Active Pharmaceutical Ingredients (API) Product
Table 121. DSM Recent Development
Table 122. Aurobindo Pharma Company Information
Table 123. Aurobindo Pharma Introduction and Business Overview
Table 124. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 125. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product
Table 126. Aurobindo Pharma Recent Development
Table 127. Aspen Company Information
Table 128. Aspen Introduction and Business Overview
Table 129. Aspen Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 130. Aspen Active Pharmaceutical Ingredients (API) Product
Table 131. Aspen Recent Development
Table 132. Novartis Company Information
Table 133. Novartis Introduction and Business Overview
Table 134. Novartis Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 135. Novartis Active Pharmaceutical Ingredients (API) Product
Table 136. Novartis Recent Development
Table 137. BASF Company Information
Table 138. BASF Introduction and Business Overview
Table 139. BASF Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 140. BASF Active Pharmaceutical Ingredients (API) Product
Table 141. BASF Recent Development
Table 142. Pfizer Company Information
Table 143. Pfizer Introduction and Business Overview
Table 144. Pfizer Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 145. Pfizer Active Pharmaceutical Ingredients (API) Product
Table 146. Pfizer Recent Development
Table 147. Huahai Pharmaceutical Company Information
Table 148. Huahai Pharmaceutical Introduction and Business Overview
Table 149. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 150. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product
Table 151. Huahai Pharmaceutical Recent Development
Table 152. Hisun Pharmaceutical Company Information
Table 153. Hisun Pharmaceutical Introduction and Business Overview
Table 154. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 155. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product
Table 156. Hisun Pharmaceutical Recent Development
Table 157. Sun Pharmaceutical Industries Company Information
Table 158. Sun Pharmaceutical Industries Introduction and Business Overview
Table 159. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 160. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product
Table 161. Sun Pharmaceutical Industries Recent Development
Table 162. Zhejiang Medicine Company Information
Table 163. Zhejiang Medicine Introduction and Business Overview
Table 164. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 165. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product
Table 166. Zhejiang Medicine Recent Development
Table 167. Dr. Reddy’s Laboratories Company Information
Table 168. Dr. Reddy’s Laboratories Introduction and Business Overview
Table 169. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 170. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Product
Table 171. Dr. Reddy’s Laboratories Recent Development
Table 172. Zhejiang NHU Company Information
Table 173. Zhejiang NHU Introduction and Business Overview
Table 174. Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 175. Zhejiang NHU Active Pharmaceutical Ingredients (API) Product
Table 176. Zhejiang NHU Recent Development
Table 177. Bayer Company Information
Table 178. Bayer Introduction and Business Overview
Table 179. Bayer Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 180. Bayer Active Pharmaceutical Ingredients (API) Product
Table 181. Bayer Recent Development
Table 182. NCPC Company Information
Table 183. NCPC Introduction and Business Overview
Table 184. NCPC Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 185. NCPC Active Pharmaceutical Ingredients (API) Product
Table 186. NCPC Recent Development
Table 187. AbbVie Company Information
Table 188. AbbVie Introduction and Business Overview
Table 189. AbbVie Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 190. AbbVie Active Pharmaceutical Ingredients (API) Product
Table 191. AbbVie Recent Development
Table 192. Shandong Xinhua Pharmaceutical Company Information
Table 193. Shandong Xinhua Pharmaceutical Introduction and Business Overview
Table 194. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 195. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product
Table 196. Shandong Xinhua Pharmaceutical Recent Development
Table 197. Northeast Pharm Company Information
Table 198. Northeast Pharm Introduction and Business Overview
Table 199. Northeast Pharm Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 200. Northeast Pharm Active Pharmaceutical Ingredients (API) Product
Table 201. Northeast Pharm Recent Development
Table 202. Harbin Pharmaceutical Company Information
Table 203. Harbin Pharmaceutical Introduction and Business Overview
Table 204. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 205. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product
Table 206. Harbin Pharmaceutical Recent Development
Table 207. LKPC Company Information
Table 208. LKPC Introduction and Business Overview
Table 209. LKPC Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (Million USD), Price (USD/Ton) and Gross Margin (2018-2023)
Table 210. LKPC Active Pharmaceutical Ingredients (API) Product
Table 211. LKPC Recent Development
Table 212. Key Raw Materials Lists
Table 213. Raw Materials Key Suppliers Lists
Table 214. Active Pharmaceutical Ingredients (API) Market Trends
Table 215. Active Pharmaceutical Ingredients (API) Market Drivers
Table 216. Active Pharmaceutical Ingredients (API) Market Challenges
Table 217. Active Pharmaceutical Ingredients (API) Market Restraints
Table 218. Active Pharmaceutical Ingredients (API) Distributors List
Table 219. Active Pharmaceutical Ingredients (API) Downstream Customers
Table 220. Research Programs/Design for This Report
Table 221. Key Data Information from Secondary Sources
Table 222. Key Data Information from Primary Sources
List of Figures
Figure 1. Active Pharmaceutical Ingredients (API) Product Picture
Figure 2. Global Active Pharmaceutical Ingredients (API) Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Active Pharmaceutical Ingredients (API) Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Active Pharmaceutical Ingredients (API) Sales Status and Outlook (2018-2029) & (Tons)
Figure 5. Product Picture of Synthetic APIs
Figure 6. Global Synthetic APIs Sales YoY Growth (2018-2029) & (Tons)
Figure 7. Product Picture of Biotech APIs
Figure 8. Global Biotech APIs Sales YoY Growth (2018-2029) & (Tons)
Figure 9. Global Active Pharmaceutical Ingredients (API) Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2022 & 2029
Figure 11. North America Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Type in 2022
Figure 12. North America Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Type in 2022
Figure 13. Europe Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Type in 2022
Figure 14. Europe Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Type in 2022
Figure 17. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Active Pharmaceutical Ingredients (API) Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Active Pharmaceutical Ingredients (API) Revenue in 2022
Figure 23. Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of CNS
Figure 25. Global CNS Sales YoY Growth (2018-2029) & (Tons)
Figure 26. Product Picture of Cardiovascular
Figure 27. Global Cardiovascular Sales YoY Growth (2018-2029) & (Tons)
Figure 28. Product Picture of Genitourinary/Hormonal Drugs
Figure 29. Global Genitourinary/Hormonal Drugs Sales YoY Growth (2018-2029) & (Tons)
Figure 30. Product Picture of Respiratory
Figure 31. Global Respiratory Sales YoY Growth (2018-2029) & (Tons)
Figure 32. Product Picture of Rheumatology
Figure 33. Global Rheumatology Sales YoY Growth (2018-2029) & (Tons)
Figure 34. Product Picture of Diabetes
Figure 35. Global Diabetes Sales YoY Growth (2018-2029) & (Tons)
Figure 36. Product Picture of Oncology
Figure 37. Global Oncology Sales YoY Growth (2018-2029) & (Tons)
Figure 38. Product Picture of Others
Figure 39. Global Others Sales YoY Growth (2018-2029) & (Tons)
Figure 40. Global Active Pharmaceutical Ingredients (API) Sales by Application (2018-2029) & (US$ Million)
Figure 41. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2022 & 2029
Figure 42. North America Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Application in 2022
Figure 43. North America Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Application in 2022
Figure 44. Europe Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Application in 2022
Figure 45. Europe Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Application in 2022
Figure 48. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Active Pharmaceutical Ingredients (API) Manufacturing Cost Structure
Figure 53. Active Pharmaceutical Ingredients (API) Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed